{"transactions":[{"id":2944588,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":144648,"kind":"person","name":"Papkoff Jacqueline Sybil","position":1,"cik":"0001735729","reported_name":"Papkoff Jacqueline Sybil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-CSO Microbiome"}}],"security":"Common Stock","published_at":"2020-12-15T21:18:17.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":1297,"price":6.1548,"value":7982.7756,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and represents shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.12 to $6.25, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":37364,"source":{"system":"sec-edgar","filing":"0001209191-20-063666","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1735729/000120919120063666/doc4.xml","form_type":"4"}},{"id":3190979,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":144648,"kind":"person","name":"Papkoff Jacqueline Sybil","position":1,"cik":"0001735729","reported_name":"Papkoff Jacqueline Sybil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-CSO Microbiome"}}],"security":"Common Stock (right to buy)","published_at":"2020-03-31T16:16:45.000Z","date":"2020-03-27","kind":"grant","acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on March 29, 2021; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2024."}],"balance_after":34000,"derivative":{"exercise_price":14.45,"expiration_date":"2030-03-27","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001209191-20-021800","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1735729/000120919120021800/doc4.xml","form_type":"4"}},{"id":3190978,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":144648,"kind":"person","name":"Papkoff Jacqueline Sybil","position":1,"cik":"0001735729","reported_name":"Papkoff Jacqueline Sybil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-CSO Microbiome"}}],"security":"Common Stock","published_at":"2020-03-31T16:16:45.000Z","date":"2020-03-30","kind":"sale","acquired":false,"shares":1254,"price":14.2192,"value":17830.8768,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and represents shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.05 to $14.79, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":38661,"source":{"system":"sec-edgar","filing":"0001209191-20-021800","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1735729/000120919120021800/doc4.xml","form_type":"4"}},{"id":3190977,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":144648,"kind":"person","name":"Papkoff Jacqueline Sybil","position":1,"cik":"0001735729","reported_name":"Papkoff Jacqueline Sybil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-CSO Microbiome"}}],"security":"Common Stock","published_at":"2020-03-31T16:16:45.000Z","date":"2020-03-27","kind":"grant","acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units. The restricted stock units vest in four equal installments, assuming continuous service on each vesting date, as follows: March 29, 2021; March 29, 2022; March 29, 2023; and March 29, 2024."}],"balance_after":39915,"source":{"system":"sec-edgar","filing":"0001209191-20-021800","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1735729/000120919120021800/doc4.xml","form_type":"4"}},{"id":3341070,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":144648,"kind":"person","name":"Papkoff Jacqueline Sybil","position":1,"cik":"0001735729","reported_name":"Papkoff Jacqueline Sybil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-CSO Microbiome"}}],"security":"Common Stock","published_at":"2019-12-16T17:21:53.000Z","date":"2019-12-13","kind":"sale","acquired":false,"shares":1460,"price":21.0011,"value":30661.606,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and represents shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.02, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within."}],"balance_after":22915,"source":{"system":"sec-edgar","filing":"0001209191-19-060715","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1735729/000120919119060715/doc4.xml","form_type":"4"}},{"id":3403227,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":144648,"kind":"person","name":"Papkoff Jacqueline Sybil","position":1,"cik":"0001735729","reported_name":"Papkoff Jacqueline Sybil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP-CSO Microbiome"}}],"security":"Stock Options (right to buy)","published_at":"2019-10-01T18:10:02.000Z","date":"2019-10-01","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% shall vest on the first anniversary of the date of grant, October 1, 2020; and the remaining 75% shall vest in 36 approximately equal monthly installments, with the options becoming fully vested on October 1, 2023."}],"balance_after":27500,"derivative":{"exercise_price":9.31,"expiration_date":"2029-10-01","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001209191-19-051359","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1735729/000120919119051359/doc4.xml","form_type":"4"}},{"id":3569040,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":144648,"kind":"person","name":"Papkoff Jacqueline Sybil","position":1,"cik":"0001735729","reported_name":"Papkoff Jacqueline Sybil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2019-04-02T16:38:48.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% shall vest on the first anniversary of the date of grant, March 29, 2020; and the remaining 75% shall vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2023."}],"balance_after":27500,"derivative":{"exercise_price":19.69,"expiration_date":"2029-03-29","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001144204-19-017753","document":"tv517880_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1735729/000114420419017753/tv517880_4.xml","form_type":"4"}},{"id":3569039,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":144648,"kind":"person","name":"Papkoff Jacqueline Sybil","position":1,"cik":"0001735729","reported_name":"Papkoff Jacqueline Sybil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-04-02T16:38:48.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units. The restricted stock units vest in four equal installments, assuming continuous service on each vesting date, as follows: March 29, 2020; March 29, 2021; March 29, 2022; and March 29, 2023."}],"balance_after":24375,"source":{"system":"sec-edgar","filing":"0001144204-19-017753","document":"tv517880_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1735729/000114420419017753/tv517880_4.xml","form_type":"4"}},{"id":3730842,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":144648,"kind":"person","name":"Papkoff Jacqueline Sybil","position":1,"cik":"0001735729","reported_name":"Papkoff Jacqueline Sybil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2018-12-14T16:31:08.000Z","date":"2018-12-12","kind":"grant","acquired":true,"shares":21250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of stock options under the 2018 Plan. The stock options vest in approximately equal annual installments, assuming continuous service on each vesting date, on the first, second and third anniversaries of the date of grant."}],"balance_after":21250,"derivative":{"exercise_price":24.19,"expiration_date":"2028-12-12","underlying":"Common Stock","underlying_shares":21250},"source":{"system":"sec-edgar","filing":"0001144204-18-064671","document":"tv509185_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1735729/000114420418064671/tv509185_form4.xml","form_type":"4"}},{"id":3730841,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":144648,"kind":"person","name":"Papkoff Jacqueline Sybil","position":1,"cik":"0001735729","reported_name":"Papkoff Jacqueline Sybil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-12-14T16:31:08.000Z","date":"2018-12-12","kind":"grant","acquired":true,"shares":10625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable under a time-based restricted stock unit (RSU) award dated December 12, 2018 that was granted under Assembly Biosciences, Inc.'s 2018 Stock Incentive Plan (2018 Plan). The RSUs vest in approximately equal annual installments, assuming continuous service on each vesting date, on the first, second and third anniversaries of the date of grant."}],"balance_after":10625,"source":{"system":"sec-edgar","filing":"0001144204-18-064671","document":"tv509185_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1735729/000114420418064671/tv509185_form4.xml","form_type":"4"}},{"id":3977005,"issuer":{"id":5216,"kind":"organization","name":"ASSEMBLY BIOSCIENCES, INC."},"owners":[{"id":144648,"kind":"person","name":"Papkoff Jacqueline Sybil","position":1,"cik":"0001735729","reported_name":"Papkoff Jacqueline Sybil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock Option (right to buy)","published_at":"2018-04-02T18:11:01.000Z","date":"2018-04-02","kind":"grant","acquired":true,"shares":106200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% shall vest on the first anniversary of the date of grant, April 2, 2019; and the remaining 75% shall vest in 36 equal monthly installments, with the options becoming fully vested on April 2, 2022."}],"balance_after":106200,"derivative":{"exercise_price":46.75,"expiration_date":"2028-04-02","underlying":"Common Stock","underlying_shares":106200},"source":{"system":"sec-edgar","filing":"0001144204-18-018750","document":"tv490173_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1735729/000114420418018750/tv490173_form4.xml","form_type":"4"}}]}